Tech Company Financing Transactions

PTC Therapeutics Funding Round

PTC Therapeutics secured a $26.6 million funding round on 11/10/2005. Investors included Credit Suisse, HBM Healthcare Investments and Amgen Ventures.

Transaction Overview

Company Name
PTC Therapeutics
Announced On
11/10/2005
Transaction Type
Venture Equity
Amount
$26,600,000
Round
Undisclosed
Investors

Credit Suisse (Lead Investor) (Michael Schmertzler)

HBM Healthcare Investments (Lead Investor) (Axel Bolte)

Amgen Ventures

Bay City Capital

Delphi Ventures

Novartis BioVenture Fund

Vulcan Capital

Proceeds Purpose
The proceeds of this round of financing will be applied towards the clinical development of PTC124, the advancement of our preclinical oncology and antiviral programs, and our drug discovery programs in multiple therapeutic areas.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Corporate Ct.
South Plainfield, NJ 07080
USA
Phone
(908) 222-7000
Website
www.ptcbio.com
Email Address
[email protected]
Overview
PTC (NASDAQ; PTCT) is a biopharmaceutical company focused on the discovery, development, and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms.
Profile
PTC Therapeutics LinkedIn Company Profile
Social Media
PTC Therapeutics Company Twitter Account
Company News
PTC Therapeutics News
Facebook
PTC Therapeutics on Facebook
YouTube
PTC Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stuart Peltz
  Stuart Peltz LinkedIn Profile  Stuart Peltz Twitter Account  Stuart Peltz News  Stuart Peltz on Facebook
Chief Financial Officer
Christine Utter
  Christine Utter LinkedIn Profile  Christine Utter Twitter Account  Christine Utter News  Christine Utter on Facebook
Vice President
Mary Harmon
  Mary Harmon LinkedIn Profile  Mary Harmon Twitter Account  Mary Harmon News  Mary Harmon on Facebook
VP - General Counsel
Mark Boulding
  Mark Boulding LinkedIn Profile  Mark Boulding Twitter Account  Mark Boulding News  Mark Boulding on Facebook
VP - Human Resources
Martin Rexroad
  Martin Rexroad LinkedIn Profile  Martin Rexroad Twitter Account  Martin Rexroad News  Martin Rexroad on Facebook
VP - R & D
Neil Almstead
  Neil Almstead LinkedIn Profile  Neil Almstead Twitter Account  Neil Almstead News  Neil Almstead on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/9/2005: FlowMedica venture capital transaction
Next: 11/10/2005: Advent Solar venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.